GE HealthCare Technologies Inc. (GEHC)
| Market Cap | 32.42B +1.5% |
| Revenue (ttm) | 21.27B +6.5% |
| Net Income | 1.99B -11.4% |
| EPS | 4.34 -11.1% |
| Shares Out | 451.69M |
| PE Ratio | 16.54 |
| Forward PE | 13.87 |
| Dividend | $0.14 (0.20%) |
| Ex-Dividend Date | Jul 24, 2026 |
| Volume | 2,938,744 |
| Open | 70.24 |
| Previous Close | 70.31 |
| Day's Range | 69.67 - 71.92 |
| 52-Week Range | 58.75 - 89.77 |
| Beta | 0.82 |
| Analysts | Buy |
| Price Target | 82.50 (+14.95%) |
| Earnings Date | Jul 29, 2026 |
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, an... [Read more]
Financial Performance
In 2025, GEHC's revenue was $20.63 billion, an increase of 4.84% compared to the previous year's $19.67 billion. Earnings were $2.08 billion, an increase of 4.57%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price target is $82.5, which is an increase of 14.95% from the latest price.
News
GE HealthCare expands LOGIQ e ultrasound platform with new LOGIQ e family
GE HealthCare (GEHC) announced the introduction of the LOGIQ e family, featuring LOGIQ e Xi and LOGIQ e Si, two compact laptop ultrasound systems designed to help clinicians deliver fast…
GE HealthCare expands the LOGIQ e ultrasound platform with new LOGIQ e family
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced the introduction of the LOGIQ™ e family, featuring LOGIQ™ e Xi and LOGIQ™ e Si, two compact laptop ultrasound systems designed to help clinician...
GE HealthCare expands breast imaging portfolio with Invenia ABUS Prime
GE HealthCare (GEHC) announced the launch of Invenia ABUS Prime and ABUS StreamVue, a redesigned enterprise viewer that recently received U.S. Food and Drug Administration, FDA, 510(k) clearance and C...
GE HealthCare expands breast imaging portfolio with Invenia ABUS Prime and launch of ABUS StreamVue
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced the launch of Invenia™ ABUS (Automated Breast Ultrasound) Prime and ABUS StreamVue™, a redesigned enterprise viewer that recently received U.S. ...
GE HealthCare price target raised to $73 from $67 at UBS
UBS raised the firm’s price target on GE HealthCare (GEHC) to $73 from $67 and keeps a Neutral rating on the shares.
GE HealthCare price target raised to $70 from $65 at JPMorgan
JPMorgan raised the firm’s price target on GE HealthCare (GEHC) to $70 from $65 and keeps a Neutral rating on the shares.
GE HealthCare price target raised to $84 from $80 at Evercore ISI
Evercore ISI raised the firm’s price target on GE HealthCare (GEHC) to $84 from $80 and keeps an Outperform rating on the shares.
GE HealthCare price target raised to $75 from $69 at Citi
Citi raised the firm’s price target on GE HealthCare (GEHC) to $75 from $69 and keeps a Neutral rating on the shares. The firm views the company’s Q2 report as…
GE HealthCare price target raised to $79 from $75 at BTIG
BTIG raised the firm’s price target on GE HealthCare (GEHC) to $79 from $75 and keeps a Buy rating on the shares following quarterly results. The firm sees Q2 results…
GE HealthCare Technologies Earnings Call Transcript: Q2 2026
Orders grew 11% year-over-year with record backlog, and revenue rose 3.5% organically, driven by strong performance in Advanced Imaging and Pharmaceutical Diagnostics. PCS faced operational challenges but is expected to recover in the second half. Full-year guidance is maintained.
GE HealthCare Technologies Slides: Q2 2026
GE HealthCare Technologies has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
GE HealthCare Technologies Earnings release: Q2 2026
GE HealthCare Technologies released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
GE HealthCare Technologies Quarterly report: Q2 2026
GE HealthCare Technologies has published its Q2 2026 quarterly earnings report on July 29, 2026.
GE HealthCare Stock Soars After Earnings. Here's What Drove the Profit Gains.
GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.3 billion, respectively.
GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refunds
GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed under U.S. President Don...
GE HealthCare Posts Higher Profit, Revenue on Increased Orders
GE HealthCare Technologies notched higher profit and revenue in the second quarter, boosted by increased orders across the business.
GE HealthCare reports Q2 adjusted EPS $1.13, consensus $1.04
Reports Q2 revenue $5.3B, consensus $5.26B. GE HealthCare (GEHC) President and CEO Peter Arduini said, “We delivered record orders and backlog in the second quarter, with orders growth across every…
GE HealthCare reports second quarter 2026 financial results
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2026. GE HealthCare President and CEO Peter Arduini said, “We delivered re...
GE HealthCare sees Q2 earnings growth above prior expectation
GE HealthCare (GEHC) said, “Today, the Company is also providing certain preliminary, unaudited results for the second quarter ending June 30, 2026. GE HealthCare expects to report year-over-year Reve...
Correction: GE HealthCare affirms 2026 adjusted EPS outlook of $4.80-$5.00
17:38 EDT Correction: GE HealthCare (GEHC) affirms 2026 adjusted EPS outlook of $4.80-$5.00
GE HealthCare affirms fiscal 2026 outlook provided on April 29
GE HealthCare (GEHC) said, “For the full-year 2026, the company reaffirms guidance provided on April 29, 2026. The Company will provide additional details when it reports complete second quarter resul...
GE HealthCare CFO to step down
GE HealthCare said on Thursday that its Chief Financial Officer Jay Saccaro will step down from his role to pursue an opportunity outside the medical technology industry.
GE HealthCare names George Newcomb interim CFO
GE HealthCare (GEHC) announced that Jay Saccaro will step down as Vice President and Chief Financial Officer for an expanded role outside of the medical technology industry. The Company has…
GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced that Jay Saccaro will step down as Vice President and Chief Financial Officer for an expanded role outside of the medical technol...
GE HealthCare announces introduction of MIM Anyware
GE HealthCare (GEHC) announced the introduction of MIM Anyware, a remote access platform that provides secure, healthcare system-controlled access to imaging data through a web browser without requiri...